Pharmatop

Pharmatop is a French pharmaceutical research and development company specializing in the formulation of injectable medicines. The company achieved international prominence for developing the first stable, ready-to-use intravenous solution of paracetamol (acetaminophen). This innovation was licensed to Bristol Myers Squibb and marketed as Perfalgan, becoming a standard of care in hospital settings for pain and fever management. Pharmatop's core expertise lies in galenic chemistry and the stabilization of active pharmaceutical ingredients in liquid forms. Based in Orléans, the company continues to focus on the development of value-added injectable products and intellectual property. Its business model typically involves partnering with larger pharmaceutical manufacturers for the commercialization and distribution of its developed therapies.